Veterinary surgeons in the UK were invited to complete an internet survey concerning their attitudes to chronic pain in dogs. UK veterinary surgeons numbering 215 completed surveys in full along with 48 worldwide specialists in anaesthesia and 37 worldwide specialists in oncology. Osteoarthritis, dental and aural disease, vertebral and spinal cord conditions, neoplasia and skin conditions were considered important causes of chronic pain in dogs. UK practitioners used significantly fewer classes of analgesic drugs regularly than either category of specialist. The major barriers to adequate treatment of chronic pain were reported as difficulties with pain assessment, expense of drugs, and difficulties with owner compliance. Illustrations of six common neoplastic conditions were used and scored for pain according to prior experience by practitioners. All six conditions were consistently described as involving some degree of pain with primary bone tumour and oral tumour, causing severe pain and moderate to severe pain, respectively. Years since graduation and specialist status affected the pain scores attributed to the conditions. There was a significant correlation between the pain score attributed to the illustrated condition, and the tendency to administer analgesia.
Introduction
The International Association for the Study of Pain (ISAP) defines chronic pain as pain without apparent biological value that has persisted beyond the normal tissue healing time (Merskey and Bogduk 1994) . In recent years, there has been an increased focus in veterinary medicine on the diagnosis and management of chronic pain (Fox 2012 ). This change is evidenced by an emphasis on pain management in books and continuing education, and also by the recent development of a number of novel instruments to measure chronic pain and its effect on quality of life in veterinary patients (Wiseman-Orr and others 2006 , Brown and others 2008 , Hielm-Björkman and others 2009 , Mölsä and others 2013 , Reid and others 2013b . While the exact prevalence of chronic pain in companion animals is unknown, degenerative and neoplastic processes which are frequently associated with pain, are leading causes of mortality in dogs (Fleming and others 2011) . Osteoarthritis is widely regarded as a common cause of chronic pain. It has been estimated that 20 per cent of adult dogs suffer from this (Johnston 1997) , and hence may experience chronic pain.
In human medicine, pain is one of the most common symptoms associated with cancer. The prevalence of chronic pain in patients with newly diagnosed cancer is 30-50 per cent, rising to 70-90 per cent in those with advanced disease (Colvin and Lambert 2008) . While there are undeniable differences between human and veterinary oncology, the treatment of animals with cancer is becoming more commonplace as knowledge and diagnostic/treatment modalities improve and evolve. It has been estimated that 30 per cent of tumours in dogs and cats are associated with some degree of pain at the time of diagnosis (Lascelles 2012) . No studies address the epidemiology of cancer pain in veterinary medicine although there is evidence that pain associated with cancer can have a significant effect on quality of life (Yazbek and Fantoni 2005 , Brown and others 2009 , Flôr and others 2013 .
The results of a number of surveys regarding veterinary perceptions of acute, perioperative pain have been published in the last 15 years others 1999, Lascelles and others 1999) . Despite increasing interest in the diagnosis and treatment of chronic pain in dogs, only one survey has been conducted to assess practitioners' attitudes to chronic pain treatment and was only concerned with osteoarthritis (Bound and others 2011) . Using a survey, the aims of this study were to  Determine the most commonly perceived causes of chronic pain in dogs in UK practice.  Determine the classes of analgesic drugs commonly administered to dogs with chronic pain.  Determine how painful different cancers are in the eyes of practitioners.  Determine how often analgesia is administered to cancer pain patients.  Analyse trends in the above according to demographics.
Materials and methods
An internet-based survey designed to be completed by veterinary surgeons was developed (SurveyMonkey, California, USA (www. surveymonkey.com)). Ethical approval was granted by the School of Veterinary Medicine ethical review committee and data collected were anonymous. The survey was available online between June and September 2012. A letter asking practitioners to complete the survey was sent to 500 UK veterinary surgeons in June 2012. The veterinary surgeons were selected randomly from a UK database of veterinary practices listed as dealing with small animals. Letters containing the link were published in the Veterinary Record and the Veterinary Times. No incentives were provided for survey completion.
Invitations to complete the survey were also sent to two separate groups of veterinary specialists, anaesthetists and oncologists, via worldwide specialist interest email lists (anaesthesia; ACVA-list. Oncology; ACVIM-onc list). These invitations contained different links to the survey which distinguished responses from these two cohorts from the UK practitioner responses. Data were collected about dogs, and the survey was divided into six separate parts. Part 1 consisted of questions relating to: respondent gender, year graduated from veterinary school, practice type (mixed/small animal/referral), postgraduate qualifications and the percentage of time spent treating small animals. Part 2 investigated the conditions causing chronic pain in the dog. The respondents were asked to rank the top three most common conditions causing chronic pain in dogs according to their experience. Respondents could select from: chronic cystitis, chronic pancreatitis, chronic postoperative pain, dental disease, ear disease, myofascial pain, neoplasia, neuropathies, ocular conditions, osteoarthritis, skin disease, vertebral and spinal cord conditions or other (with space for comment). The conditions were presented in random order by the survey website. Part 3 concerned the analgesics that can be used for chronic pain in dogs, and respondents were asked to rank the analgesics as: always used, often used, occasionally used, rarely used and never used. Part 4 examined pain assessment and is not presented here. Part 5 addressed the perceived barriers to adequate treatment of chronic pain in dogs. Veterinary surgeons were asked to rank a number of potential barriers as: major, minor or insignificant. The potential barriers listed were: difficulties with pain assessment, side effects of drugs, expense of drugs, lack of analgesics with a veterinary license, inadequate knowledge of pain treatment, difficulties with owner compliance, inadequate time to deal with cases and poor efficacy of available drugs. Part 6 investigated attitudes to pain associated with cancer in dogs. Six photographs of different neoplasms were presented, and the veterinary surgeons were asked to rank the pain they would associate with that condition using a numerical rating scale with 0 representing no pain and 10 representing the worst pain imaginable. The six neoplasms used were: primary bone tumour, skin tumour, lung tumours, oral tumour, mammary tumour and lymphosarcoma (Fig 1) . For each of the conditions, respondents were then asked how often they would prescribe analgesic therapy (always/often/occasionally/rarely/never). Then respondents were asked what percentage of patients with tumours suffer some degree of pain lasting more than one month. Finally, respondents were asked to indicate their level of agreement with the following two statements: 'pain associated with cancer is underdiagnosed' and 'pain associated with cancer is easy to treat'.
Results were analysed in SPSS statistics (IBM, New York, USA). Initially, the duplicates toolwas used to ensure no duplicate entries had been made based on IP address and demographic data. After confirming that data was normally distributed, t tests and analysis of variance were used to compare analgesic use and Likert responses to questions. The average pain score was calculated as the mean of the numerical pain scores attributed to all the conditions. The Likert scale items describing frequency of analgesic use were assigned interval values from 1 (never) to 5 (always). A respondent's tendency to give analgesia was calculated as the mean of these values for all six conditions. The influence of variables on pain scores was analysed using a stepwise multivariate linear regression model, with pain score as the dependent variable. Independent variables for inclusion in the model were: years graduated, gender, collector group (practitioner/oncologist/anaesthetist) and practice type. To allow regression analysis, categorical variables were recoded into individual dichotomous variables. χ 2 Tests were used to compare categorical responses between collector groups.
Results

Demographics
Three hundred online surveys were completed in full; 215 by UK practitioners, 48 by veterinary anaesthetists and 37 by veterinary oncologists, and no duplicates were detected. Thirty-eight per cent (114) of respondents were female and 62 per cent (186) were male. Respondents graduated from veterinary school between 1 and 48 years ago, and the mean years since graduation was 15±10 (±sd). Seventy-eight per cent of the practitioners were in small animal general practice; 9 and 15 per cent were in referral and mixed practice, respectively. One hundred per cent of veterinary oncologists surveyed were in referral practice. Seventy-one per cent of the anaesthetist respondents were in referral practice, 6 per cent in general practice and 23 per cent in other (universities and research). Ninety-three per cent of respondents worked with small animals greater than 75 per cent of the time, and 83 per cent of respondents did so greater than 90 per cent of the time.
One hundred per cent of veterinary oncologists surveyed had formal further qualifications in veterinary oncology, and 89 per cent of the veterinary anaesthetists had further qualifications related to anaesthesia. Twenty per cent of UK practitioners surveyed had some form of further qualification, which was related to anaesthesia or analgesia in 3 per cent of cases. One hundred per cent of UK practitioners practiced in Britain, 86 per cent of veterinary oncologists were based in the USA, with the remaining 14 per cent distributed through a number of other countries worldwide. Thirty-three per cent, 39 per cent and 6 per cent of veterinary anaesthetists surveyed were based in the UK, the USA and Australia, respectively. The remaining 22 per cent were based in various other countries worldwide.
Common conditions
The percentages of UK practitioner respondents rating a certain condition as either the most common cause of chronic pain in their practice, or one of the top three causes are shown in Table 1 .
Ranking by these percentages, the most common causes of chronic pain in this survey are osteoarthritis, dental disease, ear disease, vertebral and spinal cord conditions, neoplasia and skin conditions, in that order.
Analgesics used for chronic pain
The classes of analgesics used by UK practitioners for the management of chronic pain are shown in Fig 2. UK practitioners used an average of 5 (3-6) (median, (IQR)) classes of drug to treat chronic pain either always, often, or occasionally. Classes of analgesics used by veterinary anaesthetists (7 (6-8)) and oncologists (8 (7-9)) was significantly greater than UK practitioners (P<0.001). Anaesthetist and oncologist respondents used all classes of analgesic more frequently (either always or often) compared with practitioners (P<0.01), with the exception of homeopathy.
Barriers to treatment
Fig 3 summarises responses from the UK practitioners group concerning the barriers to adequate treatment of chronic pain in dogs.
Comparison between collector groups demonstrated no significant differences in response between groups concerning time, side effects, efficacy, or licensing as perceived barriers. There were significant differences (P<0.01 in each case) in terms of assessment, expense, knowledge and compliance as perceived barriers. Fifty-seven per cent of oncologists and 54 per cent of anaesthetists rated difficulties with pain assessment as a major barrier compared to 33 per cent of practitioners. Thirty-nine per cent of practitioners rated expense as a major barrier compared to 25 per cent of anaesthetists and 18 per cent of oncologists. Twenty-five per cent of anaesthetists cited lack of knowledge as a major barrier compared to 8 per cent of oncologists and practitioners. Fifty-two per cent of practitioners rated client compliance as a major barrier compared to 21 per cent of oncologists and 25 per cent of anaesthetists.
Pain scores for neoplastic conditions
The mean pain scores attributed by all respondents are summarised in Table 2 . Multivariate linear regression models investigating the influence of variables on each pain score are summarised in Table 3 .
Administration of analgesia for neoplastic conditions
Tendency to give analgesia was significantly correlated with the overall average pain scores of those surveyed (P=0.000, R=0.57). The frequency of analgesic administration by practitioners for each condition is summarised in Fig 4. There were no significant differences between collector groups (practitioners/oncologists/anaesthetists) in terms of the administration of analgesics for each condition.
Responses to other questions
Responses to the question, 'What percentage of patients with tumours suffer some degree of pain lasting more than one month?' are summarised in For the question 'pain associated with cancer is underdiagnosed' there were no significant differences in the mean answer score relating to sex or years graduated. Those respondents with further qualification in anaesthesia agreed with this statement more than the other groups (P=0.002). There were no significant differences in the mean answers score for the question 'pain associated with cancer is easy to treat' with sex, years graduated, or specialist status.
Discussion
Osteoarthritis being perceived as the most common cause of chronic pain in the dog is unsurprising. It has been identified as the number one cause of chronic pain in dogs (Fox 2010) and is estimated to affect 20 per cent of the adult canine population (Johnston 1997) .
Dental and aural disease would appear to be important causes of chronic pain in UK practice. Dental disease is the most commonly reported disorder in dogs presenting to general practitioners in the USA (Lund and others 1999) and the pathophysiology of chronic pain caused by dental disease has been described (Beckman 2006) . Aural and dental disease are considered frequently overlooked causes of pain by the authors of recently published pain management guidelines (Hellyer and others 2007) , and their recognition by practitioners is encouraging. Unfortunately, this survey did not establish the proportion of these cases treated with analgesics although many of the causes of dental and oral pain are amenable to curative treatments, such as surgery or dental procedures.
Vertebral and spinal cord conditions were also perceived as a relatively common cause of chronic pain. These conditions are widely recognised as a cause of pain but comprise multiple neurological and non-neurological causes (Platt and Freeman 2013 ) the relative importance of which were not investigated here. Chronic pain attributable to nervous system damage may be particularly challenging to treat as the pain is frequently neuropathic in origin (Mathews 2008, Rusbridge and Jeffery 2008) . Neoplasia was the fifth most common cause of chronic pain identified in the survey, and is discussed in more detail below.
NSAIDs were the most commonly reported analgesic agents by practitioners for the treatment of chronic pain. This is not an unexpected finding, as many NSAIDs are licensed and available for dogs (KuKanich and others 2012). NSAIDs appear to be efficacious and relatively safe, particularly in the treatment of chronic pain due to osteoarthritis (Innes and others 2010) . Opioids were the second most commonly used analgesic by practitioners. Although commonly used in human beings (Chen and others 2011) , their chronic use is limited in veterinary medicine by the poor oral bioavailability of commonly used drugs (KuKanich and others 2005a, b, KuKanich 2010). Tramadol is a synthetic opioid analgesic with acceptable oral bioavailability in dogs (KuKanich and Papich 2004) . Oral administration of tramadol in dogs may not yield adequate concentrations of the active metabolite, and thus, may not provide effective analgesia (Giorgi and others 2009) . However, tramadol has been evaluated as an analgesic for chronic pain associated with cancer and osteoarthritis with promising results (Malek and others 2012, Flôr and others 2013) , although data on safety and efficacy is still sparse (Lascelles, 2012) . Although not explicitly stated in the survey, the popularity of opioids in the treatment of chronic pain is assumed to be due to the use of tramadol in veterinary practice.
Generally, practitioners expressed an occasional to rare level of use of corticosteroids, gabapentin, acupuncture and physiotherapy.
Corticosteroids are analgesic due to their anti-inflammatory effect, and another survey demonstrated that they were used occasionally in the management of osteoarthritis (Bound and others 2011) , in agreement with our findings. Limited evidence supports the efficacy of gabapentin for chronic pain in animals, although it appears efficacious in a wide range of chronically painful conditions in human beings (Kong and Irwin 2007) and is widely recommended as a treatment for neuropathic pain in veterinary medicine (Mathews 2008) . Acupuncture and physiotherapy are widely available in general practice, and the popularity of their use in chronic pain is supported here. There is no compelling evidence to support the use of either of these treatments in chronic pain in dogs (Habacher and others 2006, Bound and others 2011) , although anecdotal reports of both treatments are encouraging (Lindley 2006 , Hunter 2010 .
N-methyl-D-aspartate (NMDA) antagonists, radiotherapy, bisphosphonates, amitriptyline and homeopathy as treatments for chronic pain were generally used either rarely or never by practitioners. There is some limited evidence in veterinary medicine that these treatments, with the exception of homeopathy, are efficacious in chronic pain (Chew and others 1998 , Ramirez and others 1999 , Fan and others 2007 , Lascelles and others 2008 . Treatments such as radiotherapy are not generally directly available to UK general practitioners, and along with bisphosphonates are also only analgesics in quite specific chronic pain syndromes, that is, bone cancer where animals with moderate to advanced disease may be euthanased for welfare reasons rather than being treated. The infrequent use of analgesics, such as NMDA antagonists, amitriptyline, radiotherapy and bisphosphonates may also reflect a relative lack of knowledge among general practitioners regarding chronic pain treatment, although lack of knowledge was only identified as a minor barrier to chronic pain treatment in this study. Specialist respondents with further training in either oncology or anaesthesia were likely to use more classes of analgesics regularly, and this may reflect increased knowledge, greater availability of these drugs/techniques in specialist practice, and possibly the severity of cases being seen by specialists compared to general practitioners.
Difficulties with pain assessment, expense of drugs and difficulties with owner compliance were the most commonly cited major barriers to adequate treatment of chronic pain in dogs in this survey. The diagnosis and assessment of chronic pain in dogs is regarded as challenging due to the way it affects the animal's wellbeing (Reid and others 2013a) . A wide range of often subtle behavioural disturbances have been identified in dogs with chronic pain which highlight the importance of well educated owners as behavioural observers in chronic pain assessment (Wiseman -Orr and others 2004) . The expense of drugs is clearly a valid concern in the treatment of chronic pain, as treatment may be required for a long duration and animals may receive a number of different drugs as treatment, thus increasing the cost. Actual owner compliance with drug administration can differ from owner reports, but studies have only been concerned with short courses of antibiotics (Adams and others 2005) . It is perhaps surprising that compliance is listed as a major barrier, as one might think that owners who observed behavioural signs of pain in their dogs would be driven to administer analgesic medications. Further investigation here seems warranted, as this discrepancy could be due to owners not recognising behavioural signs of pain.
Cancer pain may be due to the tumour itself, the treatments used (e.g., immunosuppression and infection due to chemotherapeutic agents or surgical intervention), debility caused by the tumour or concurrent diseases frequently present in older animals (Looney 2010) . There are multiple mechanisms by which the tumour itself can cause pain, including mechanical distension of tissues, inflammation, release of active pain-generating mediators and nerve compression or injury causing neuropathic pain. These mechanisms have been reviewed elsewhere (Fox 2012) . These multiple mechanisms and the incurable nature of many advanced tumours mean that, when it occurs, cancer pain may be difficult to treat. This is reflected in the high level of disagreement with the statement 'pain with cancer is easy to treat'.
Of course, not all tumours are painful, and factors including the individual animal, the tumour type, comorbidities and the treatment involved, determine the incidence of pain. As veterinary surgeons, we have an ethical obligation to treat pain where it arises as a result of a tumour. Additionally, the provision of analgesia where cancer pain is present may have beneficial effects on survival (Sasamura and others 2002, Sessler and others 2008) , although it may not be clear for some time how this applies to veterinary patients. Lascelles (2012) estimated that 30 per cent of dogs and cats diagnosed with cancer, have significant pain at the time of diagnosis. Although the question asked in our survey is slightly different, when asked what percentage of patients with tumours suffered some degree of pain lasting more than one month, it would appear that the peak response among those who answered was roughly similar to the estimate given above. However, the most common answer was 'don't know'. Pain assessment has already been identified as an important barrier to adequate analgesia, and this may, in part, underlie the high proportion of respondents answering 'don't know'. This conclusion is supported by the finding that over 85 per cent of respondents in this survey agreed that pain associated with cancer was underdiagnosed.
The photographs of tumours used in the survey were chosen as they represented common cancer presentations in practice (Dobson and others 2002) . The use of photographs was designed to reduce variability in the attributed pain scores compared to written descriptions alone. However, the pain scores attributed to, for example, oral tumours in this study, may not be representative of all oral neoplasms. Practitioners were asked to assign pain scores based on their prior experience of similar presentations. Pain was scored on an 11-point scale, and this can be converted into a verbal rating scale (Breivik and others 2008) . Using this methodology, primary bone tumours were, on average, rated as severely painful, oral tumours moderate to severely painful, and skin tumours, lung tumours, mammary tumours and lymphosarcoma mild to moderately painful. Osteosarcoma is generally recognised as a severely painful condition (Brown and others 2009 ) and the high pain score attributed here is unsurprising. The oral tumour pictured was also expected to result in relatively high pain scores, as it was large, ulcerated and distorting normal dentition. It is of interest that all the other pictures of common neoplastic conditions were, on average, attributed a pain score suggesting some degree of mild to moderate pain would be involved.
Despite the normal distribution of the pain scores, the actual pain score attributed varied widely among respondents. A multivariate model was used to attempt to explain some of this variability, but the model R 2 for each pain score was low, meaning that the variability in the dependent factor could not be ascribed solely to the factors in the model. It is likely that this variability is due to factors not included in the survey, such as prior experience, ethical beliefs and outlook. A number of factors affecting pain scores were identified. The numbers of years since graduation from veterinary school had a small but significant effect on the average pain score and all individual pain scores except for those associated with primary bone tumours. For average pain score, for every 10 years since a respondent graduated from veterinary school, pain score would decrease by 0.4 points in the model. The effect of years since graduation has been documented as a factor influencing pain scores in a number of previous studies investigating perioperative analgesia (Capner and others 1999 , Lascelles and others 1999 , Raekallio and others 2003 . These prior studies have also identified gender as a significant factor affecting pain scores, with women tending to score pain higher than men. This was not evident in the results of the multivariate analysis except in the case of primary bone tumour. Men did attribute lower pain scores in this study when univarate analysis was used (not presented), but as this was not retained in the multivariate model it can be assumed that the effect was due to an older cohort of men responding than women. In the case of primary bone tumours, lung tumours and lymphosarcoma, specialist oncologists and anaesthetists tended to attribute lower pain scores. Certainly in the case of oncologists this may be due to increased familiarity with these presentations and a more realistic assessment of pain behaviours in these patients.
Prior surveys of UK veterinary practitioners have demonstrated that despite attributing high pain scores to some surgical procedures, not all surgeons considered it necessary to treat the pain others 1999, Lascelles and others 1999) . Comparison is difficult, as these studies were conducted almost 15 years ago, and attitudes to the treatment of pain may have changed significantly in that time. It is encouraging to see that in this study there was a significant correlation between the pain score attributed and the tendency to administer analgesia to the patient. In the case of bone cancer, almost 100 per cent of practitioners said they would always administer an analgesic; and for the oral tumour, 95 per cent of respondents indicated they would use an analgesic always or often.
The aim of this survey was to investigate attitudes to chronic pain among UK veterinary surgeons. However, the nature of survey research means there is likely to be some degree of bias. Questionnaire completion was entirely voluntary, and veterinary surgeons invited to participate in the survey may have had different reasons for not wishing to complete the Questionnaire, thus, the significance and direction of the bias is difficult to determine. A wide range of age groups responded to the survey and the demographics for years, since graduation and gender would appear to be broadly similar to those reported in previous studies others 1999, Bound and others 2011) , and it is therefore probable that the results are representative of the UK veterinary profession. The manner in which data was collected from the specialist groups may also have led to bias in the results. A large number of the oncologist respondents originated from North America, and this may have introduced a cultural bias. However, at the time the survey was conducted, the European College of Veterinary Internal Medicine website listed only 12 active specialists in oncology working in the UK. As such, even with a 100 per cent response rate, the number of respondents would not have gained any significance. Additionally, the use of email collector lists specific to speciality may have led to some of those veterinary surgeons with postgraduate qualifications being misclassified, for example, practitioners with further qualifications in anaesthesia being omitted from the anaesthetist category. However, analysis (not presented) shows that the number of misclassified respondents is negligible and does not alter the results of statistical comparisons. As such, the authors feel that the use of the specialist email lists ensured that veterinary surgeons with a genuine and current interest in their specialty were surveyed.
In conclusion, osteoarthritis, dental and aural conditions, spinal conditions and neoplasia would appear to be the leading causes of chronic pain, according to UK veterinary surgeons. A wide variety of drugs and techniques may be used for the treatment of chronic pain, but data concerning the efficacy and safety of these is frequently lacking. The six common neoplastic conditions illustrated in this study are commonly associated with some degree of pain, and reportedly treated as such by practitioners, but ultimately, the assessment and recognition of chronic pain in the dog is frequently a major barrier preventing appropriate treatment.
